Recently, the LIM and SH3 domain protein 1 (LASP1) was identified as a component of a six gene signature that is strongly predictive for disease progression and relapse in CML patients. The gene discussed is LASP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.